Assessment of oxygen extraction rate changes following red blood cell transfusion in the intensive care unit: a protocol for a prospective observational non-interventional study

被引:1
作者
Tuzen, Ahmet Salih [1 ]
Aksun, Murat [2 ]
Sencan, Atilla [2 ]
Girgin, Senem [1 ]
Golboyu, Birzat Emre [1 ]
Kirbas, Gizem [1 ]
Sanli, Ozan [1 ]
机构
[1] Izmir Katip Celebi Univ Ataturk Training & Res Ho, Dept Anesthesiol & Reanimat, Izmir, Turkiye
[2] Izmir Katip Celebi Univ Ataturk Training & Res Ho, Dept Intens Care Med, Izmir, Turkiye
来源
BMJ OPEN | 2023年 / 13卷 / 08期
关键词
Blood bank & transfusion medicine; Anaemia; Adult intensive & critical care; RESTRICTIVE TRANSFUSION; MANAGEMENT; ANEMIA;
D O I
10.1136/bmjopen-2023-074413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Haemoglobin transfusion thresholds have been used in the intensive care unit (ICU) to guide red blood cell transfusion (RBCT) decisions. Recent research has also focused on physiological indicators of tissue oxygenation as trigger points for blood transfusion. This study aims to assess the oxygen extraction rate (O2ER) as a critical indicator of the oxygen delivery-consumption balance in tissues and investigate its potential as a reliable trigger for blood transfusion in ICU patients by analysing clinical outcomes. The utilisation of physiological indicators may expedite the decision-making process for RBCT in patients requiring immediate intervention, while simultaneously minimising the risks associated with unnecessary transfusions.Methods and analysis This prospective, single-centre, observational cohort study will include 65 ICU patients undergoing RBCT. We will evaluate essential markers such as arterial oxygen content, central venous oxygen content, arteriovenous oxygen difference, O2ER and near-infrared spectroscopy before and 15 min after transfusion. The primary outcome is the percentage increase in O2ER between the two groups relative to the initial O2ER level. Secondary outcomes will assess complications and patient outcomes in relation to baseline O2ER. A 90-day comprehensive follow-up period will be implemented for all enrolled patients.Ethics and dissemination This study has obtained ethics committee approval from the Izmir Katip Celebi University Non-Interventional Clinical Studies Institutional Review Board. Written informed consent will be obtained from all patients before their enrolment in the study. The findings will be disseminated through publication in peer-reviewed journals and presentation at national or international conferences.Trial registration number NCT05798130
引用
收藏
页数:6
相关论文
empty
未找到相关数据